2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92542°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
KB¼ÕÇØº¸Çè-¾Æ¿öȨ, ÇコÄÉ¾î »ç¾÷ Çù·Â (2022-01-09)
¡®2019 LG ÄÚµåÁ¦·Î R9 ±×¶ûÇÁ¸®¡¯ °³ÃÖ (2019-10-29)
·¹À̺íÄÚÆÛ·¹À̼Ç, ÀϺ» ½ÃÀå ÁøÃâ (2023-05-28)
ÇÑÈ­±×·ì, ´ë¿ìÁ¶¼±Çؾç Àμö ÃÖÁ¾ ¿Ï·á (2023-05-28)
ºê·¹Àε¥Å©, Àεµ³×½Ã¾Æ ±×·¦ Åýÿ¡ ÇÑ·ù ÄÜÅÙÃ÷ (2020-02-17)
¿ÃÇØ Ű¿öµå´Â ¡®¸àÅ»Çコ¡¯ (2013-01-24)
»ï¼ºSDS, ¹Ì·¡¼ºÀå À§ÇØ 3°³ »ç¾÷¿ª·® °­È­ (2021-04-02)
¹è¿ì ±è¹ü ¼Ò¼Ó»ç, ±ºÀÔ´ë °ü·Ã °ø½ÄÀÔÀå ¹ßÇ¥ (2018-04-13)
ÀνºÅ¸±×·¥, ÀνºÅ¸±×·¥ ½ºÅ丮¿ë Æ÷Ä¿½º Ä«¸Þ¶ó Ãâ½Ã (2018-04-13)
Çö´ë·ÎÅÛ, GTX-A³ë¼± Àüµ¿Â÷ 40·® »ç¾÷ ¼öÁÖ (2020-06-24)
±¹¸³ Çѱ¹¹æ¼ÛÅë½Å´ëÇб³ ¡®±³¸í º¯°æ¡¯ °ø¸ðÀü (2023-06-14)
¼­¿ï½ºÅä¾î, ÇÁ¸®¼¼ÀÏ ¿ÀÇ ±â³ä ÆÄ°ÝÀûÀÎ À̺¥Æ® (2019-06-14)
¡®»ï¼º °¶·°½Ã ¾ðÆÑ¡¯ Æ®·¹ÀÏ·¯ ¿µ»ó 1¾ï ºä (2021-08-08)
Ä«¸á·¹¿Â¹Ìµð¾î, °í°´»ç¿Í ´©Àû 600°Ç ÀÌ»ó °Å·¡ (2022-06-03)
¹è¿ì À¯¿¬¼®, ·Ôµ¥Á¦°ú µå¸²Ä«Ä«¿À ±¤°í ¸ðµ¨ ¹ßŹ (2019-01-11)
¾È¼ºÁØ, ¡®¿¥! Ä«¿îÆ®´Ù¿î¡¯ ù Ã⿬ (2021-02-18)
°Ç¼³Çùȸ, °Ç¼³ÇöÀå Ãß°¡¹èÁ¤ ¿Ü±¹Àη °í¿ë´ëÇà (2014-04-21)
Samsung Electronics and Galaxy Community Generate Over USD 1... (2022-12-25)
¾ÆÀ̵¹ ÃÖÃÊ! µ¿¼­ÀÚ¸ÅÁö°£ ź»ý ½ºÅ丮 (2021-12-14)
Àü±¹ Ç¥ÁØÁö °ø½ÃÁö°¡ 3.64% »ó½Â (2014-02-20)
±Ø´Ü ¾Æ¶ì, Àåµ¹ ¹ð¹ð¹ð ¼¼¹øÂ° À̾߱â ÁøÇà (2020-12-03)
¡®ATO¡¯, µÎ ¹øÂ° ´í½º°î ¡®Keep On¡¯ °ø°³ (2014-12-16)
¡®È¿¼º°ú ÇÔ²²ÇÏ´Â ¿ÃÇØÀÇ ÀÛ°¡¡¯ È«¼¼Áø ¼±Á¤ (2021-12-31)
Àü±âÂ÷ Ãʰí¼Ó ÃæÀü ÀÎÇÁ¶ó È®Ãæ SPC ¼³¸³ (2022-04-21)
Á¦ÁÖ Áö¿ª¹®Á¦ µðÁöÅÐ »çȸÇõ½Å ¾ÆÀ̵ð¾î °æÁø´ëȸ (2019-10-11)
       [ÀÌÀü][1]....[2630][2631][2632][2633][2634][2635][2636][2637][2638]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..